The emphasis on regular screenings and diagnostic tests enables early detection of health issues in women, leading to timely intervention and improved treatment outcomes. This proactive approach to healthcare not only improves individual patient outcomes but also contributes to reducing healthcare costs associated with advanced disease stages. Additionally, counseling and education about lifestyle modifications and risk reduction strategies further support preventive care efforts, driving market demand for women's health diagnostics.
According to Data Bridge Market Research, the Womens Health Diagnostics Market is expected to CAGR of 8.4% during the forecast period of 2022 to 2029, at USD 27.10 billion in 2021, and is further estimated to reach USD 51.67 billion by 2029.
“Rising incidence of infectious diseases in women drives the market”
The rise in the incidence of infectious diseases in women, particularly sexually transmitted diseases (STDs), has significant implications for the women's health diagnostics market. STDs can pose serious risks to the health of a fetus or infant if transmitted during pregnancy or childbirth. In the United States, STDs are a leading cause of preventable infertility. This growing awareness of the link between infectious diseases and reproductive health drives the demand for women's health diagnostics, including screening tests for STDs, prenatal testing, and early detection of infections. As a result these health concerns and ensuring timely diagnosis and treatment will fuel market growth in the coming years.
What restraints the growth of the womens health diagnostics market?
“Increased cost of diagnostic imaging systems”
The increased cost of diagnostic imaging systems poses a significant restraint on the women's health diagnostics market. These systems, such as mammography and ultrasound machines, require substantial investments for acquisition, maintenance, and operation. The high costs associated with these imaging technologies limit their accessibility, particularly in resource-constrained settings and healthcare facilities. This affordability barrier hinders the widespread adoption of advanced diagnostic imaging solutions, potentially limiting early detection and timely management of women's health conditions. Furthermore the cost issue is crucial to ensure equitable access to diagnostic services and drive market growth.
Segmentation: Womens Health Diagnostics Market
The women health diagnostics market is segmented on the basis of diagnostic devices, application, and end user.
- On the basis of diagnostic devices, the womens health diagnostics market is segmented into imaging and monitoring systems, biopsy devices, reagents and kits, biomarkers, and others.
- On the basis of application, the womens health diagnostics market is segmented into osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy and fertility testing, prenatal genetic screening and carrier testing, infectious disease testing, Std testing, and ultrasound tests.
- On the basis of end user, the womens health diagnostics market is segmented into hospitals, diagnostic and imaging centers, clinics, and home care setting.
Regional Insights: North America dominates the womens health diagnostics market
North America's dominance in the women's health diagnostics market is attributed to the increasing adoption of technologically advanced products. Government initiatives and frequent product launches are expected to drive further market growth in the region during the forecast period.
In Asia-Pacific, the market is projected to experience significant growth due to improvements in healthcare infrastructure. Government initiatives and the growing participation of women in the workforce also contribute to market expansion. Additionally, increased awareness of women's health disorders is anticipated to propel market growth in the region in the coming years.
To know more about the study visit, https://www.databridgemarketresearch.com/fr/reports/global-womens-health-diagnostics-market
Recent Developments in Womens Health Diagnostics Market
- In September 2021, Terumo Aortic commenced the PANTHER study, a global surgical transplant research project. Starting with a comprehensive evaluation of their knitted and woven surgical grafts and cardiovascular patches, the study involves multiple centers and arms. Through combining prospective and retrospective analyses, Terumo Aortic aims to assess the efficacy and safety of these products in surgical transplantation procedures.
The Prominent Key Players Operating in the Womens Health Diagnostics Market Include:
- Siemens (Germany)
- Hologic, Inc. (U.S.)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- Abbott (U.S.)
- BD (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Thermo Fisher Scientific (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- NeuroLogica Corp. (U.S.)
- Shimadzu Corporation (Japan)
- bioMérieux SA (France)
- Carestream Health (U.S.)
- MEDGYN PRODUCTS, INC. (U.S.)
- URIT MEDICAL ELECTRONIC CO., LTD (China)
- COOK (U.S.)
- Cardinal Health (U.S.)
- PerkinElmer Inc. (U.S.)
- General Electric Company (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- Danaher (U.S.)
- Sysmex Corporation (Japan)
- Hitachi, Ltd. (Japan)
- Canon Inc. (Japan)
- FUJIFILM Holdings Corporation (Japan)
Above are the key players covered in the report, to know about more and exhaustive list of womens health diagnostics market companies contact, https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Womens Health Diagnostics Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
